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ABSTRACT
The definition of late-phase response (LPR) associated
with nasal allergy is not as clear as that associated with
asthma. Furthermore, LPR and immediate-phase res-
ponse often act in concert to produce confounding
symptoms due to repeated attacks over a short period
of time. We examined the nasal airway resistance
(NAR), allergic symptoms, eosinophil cationic protein
and histamine concentration in nasal surface tissue
30 min before, and 10 min, 1, 3, 5, 7 and 9 h after a
house dust (HD) nasal challenge test was performed
twice on 10 patients with HD perennial nasal allergy.
Nasal airway resistance readings after the HD nasal
challenge test were classified into three types based on
changes in NAR: type I (short-lasting, five cases); type II
(prolonged, eight cases); and type III (biphasic, six
cases). Delayed increases in NAR were not observed in
type I patients with weak responses to nasal challenge.
In type II patients, baseline NAR was elevated and
numerous basophilic metachromatic cells (BC) were
present in the epithelial layer. In type III patients, base-
line NAR was not as elevated as it was in type II
patients, but marked responses to challenge were
noted. In all three types of changes in NAR, eosinophil
leukocyte increased at late phase. Moreover, there was
no correlation of change in NAR with an increase in
the number of eosinophil leukocyte and BC at the
epithelial layer in all three types, which suggests that
Correspondence: Dr Kimihiro Okubo, Deportment of
Otorhinolaryngology, Nippon Medical School, 1-1-5 Sendagi,
Bunkyo-ku, Tokyo 113, Japan. Email: ent-kimi@nms.ac.jp
Received 19 February 1998. Accepted for publication
30 April 1998.
further study is required to confirm the exact role of
eosinophils and basophilic cells in LPR.
Key words: antigen challenge, basophilic cells, eosino-
phil, house dust mite, late phase response, nasal airway
resistance, perennial nasal allergy.
INTRODUCTION
It is generally accepted that two types of allergic reactions
are elicited in both challenge tests and skin antigen reac-
tion tests in asthma patients: immediate-phase response
(IPR), which occurs within a few minutes of exposure to
antigens, and late-phase response (LPR), which occurs
7-10 h after exposure.' In asthma patients, LPR manifests
as airway resistance increases and lasts longer than IPR.
The two main factors which contribute to LPR are
eosinophils, which cause injury to the airway epithelium,
and T-Iymphocytes, which secrete cytokines to allow for
the local migration of eosinophils and f-lvmphocvtes.?
However, LPR is not elicited in all asthma patients.
Late-phase response, mainly nasal obstruction (increases
in airway resistance), occurs in the nasal mucosa of polli-
nosis patients in antigen challenge tests in the ofl-seoson."
However, the definition of LPR was developed as a result of
challenge with antigens in patients with allergies. The defini-
tion of LPR associated with nasal allergy is not as clear as
that associated with asthma. Furthermore, LPR and IPR often
act in concert to produce confounding symptoms due to
repeated attacks over a short period of time. The objective
of this study was to observe subjective symptoms and objec-
tive findings at a late phase after antigen challenge in
order to determine the presence or absence of LPR as
well as its characteristics. Furthermore, we aimed to clarify
the relationship between LPR and migrating cells such as
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eosinophil leukocyte and basophil metachromatic cells
(BC) in the nasal mucosa. Patients with house dust perennial
nasal allergy (HDMAR) were selected as subjects, although
they were presumed to have presented problems related to
natural dual exposure after challenge. Studies in Japanese
cedar pollinosis patients in the off-season are desirable in
order to observe pure LPR. However, the patients in this
study usually showed only slight reactions upon challenge in
the off-season, and no clear-cut results could be expected.
In order to avoid natural house dust (HD) exposure, all
patients were admitted to a clean examination room with
low HD mite levels. They were all treated under identical
conditions.
SUBJECTS
Included in this study were 10 patients with HDMAR,
eight males and two females aged between 20 and 33
years, who responded positively to the HD skin test and
nasal HD challenge test and who had mite-specific IgE
in serum and eosinophilia in nasal secretion. The dura-
tion of illness ranged between 6 and 18 years. The
severity rating at the time of the challenge test was
severe in four patients and moderate in six patients. Six
patients also showed positive reactions to Japanese
cedar pollen. However, it was unlikely that this allergen
influenced HD challenge because the test was con-
ducted in the off-season (i.e. November and December)
and patients were kept in a controlled environment in
hospital. All drugs including anti-allergic drugs and
topical steroids were prohibited for 3 weeks before the
test. No patient had experienced any acute airway
inflammation during the 1 month period preceding the
test and all patients gave informed consent for the
study.
METHODS
Three weeks before the test it was confirmed that all
subjects responded negatively to the nasal challenge
test using a blank control disc, and positively to the
nasal challenge test using a disc containing HD extract
(HD dry weight 250 /-1g). As mentioned, all anti-allergic
drugs were from this point prohibited until admission.
Patients were admitted the day before challenge and
kept under controlled conditions throughout the study
period. At 9:45 am on the following day, a negative
response to the blank control disc was confirmed in
case 1, and at 10.00 am the bilateral nasal challenge
test was conducted using the HD disc." The same tests
were conducted in case 2 and for subsequent cases at 3
min intervals. Smoking and alcohol consumption were
prohibited until the tests were completed.
The following tests and examinations were conducted
30 min before, and 10 min, 1, 3, 5, 7 and 9 h after the
nasal HD challenge test:
1. Assessment of subjective symptoms (frequency of
sneezing and degree of nasal secretion and obstruction).
2. Assessment of volume of nasal secretion (cm), deter-
mined by the thread test for nasal secretion.>
3. Test for nasal airway patency: the degree of nasal
airway patency was determined by the active anterior guide
method using a nozzle and rhinomanometer, MPR2200
(Nihon Kohden, Tokyo, Japan), after allowing patients to
blow their nose. Data were shown as bilateral nasal airway
resistance (NAR) to inspired air resistance (R) (P: 100 Pa).
When the resistance was scaled out, the value of resistance
was designated as 100 cm H20/LIs.
4. The mucous epithelial layer of the inferior turbi-
nates was scraped with a small surgical curette in order
to collect approximately 1 mg of the epithelial layer.
Tissue samples obtained were stored at -80aC in 0.5
mL of saline. They were thawed, centrifuged, and dis-
solved in 0.5 mL of saline. Freezing and thawing was
repeated three-fold before use. The histamine (HIS) and
eosinophil cationic proteins (ECP) which were released
in saline solution by the above procedure were
extracted and determined using either a methyl-hista-
mine RIA kit or an ECP kit (Pharmacia, Uppsala,
Sweden). The total amounts of HIS and ECP were con-
sidered to be indices of BC count and eosinophil
leukocyte count, respectively, in the tissue.
These tests were repeated in each subject 3 weeks later
under the same conditions. In Figs 1 and 3, No. 1-1 and
No. 1-2 indicate the 1st and 2nd tests, respectively, in
case 1.
Statistics
The paired t-test and Chi-squared test were used for the
test of statistical significance.
RESULTS
The pattern of time-course changes in the degree of
NAR were classified into three types: (i) the NAR curve
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was fl at du ring the peri od of exa min ati on and percent-
age changes were nat greater tha n 100% (type I,
sho rt-lost inq type); (ii) percentage chan ges in NAR
exceeded 100% but cha nges were mono phasic (type II,
pro lo nged type); an d cho nges in NAR were bipha sic
(immed iate- on d lat e-phose) and both peaks indicated
10 0% or greater (type III, bip hos ic type). Thus, f ive
cases were classif ied as type I (one with a severe and
five with a moderate seve rity rating); eig ht cases were
classif ied as type II (fo ur with a severe an d fou r with a
mod erate severity ratin g); and six cases wer e cla ssifi ed
as typ e III (three with a severe and th ree with a mo de rate
severity rot ing) (Fig. 1). O ne cose was excl uded from
ana lysis becau se the pa tient refused to test for nasal
a irway pa tency and to have the nasa l mucosa scrape in
the 2nd test. Reactions that ar e usuolly regarded as LPR
were classif ied os type III and o bserved in 30% of
HD M AR patients exam ined .
Subjective symptoms
Among symptoms observed immediately after antigen chal-
lenge (sneezing, nasal secretion and nasal obstruction), the
degrees of nasa l ob struction showed close correlat ion with
the changes of NAR. Sneezing was frequently noted shortly
after challenge and persisted throu ghout the observation
period in all subjects, a lthough the frequency of sneezing
varied according to the type of changes in NAR.
The incide nce of sneezing wa s low er in the type I group
than in the two other types, even sho rtly after cha lleng e
(imm ediate-phase) . In the type II group, sneezing occur-
red more than 5 h after cha llenge (late -phase) in three
coses. In the type III group, similar to the type II group,
sneezing occurred mo re than 5 h after chal lenge (Iate-
phase) in three of six cases .
Chang es in nasa l secre tion
In the type I group, the amount of nasal secretion
changed betwee n 3 and 4 em an d no apparent peak was
o bserved (Fig. 20 ). In the type II group, the mean nasal
muco us vol um e changed more than in type I an d fluctu-
ated between 2 and 6 em (Fig . 2b). In the type III group,
the mean volume was relatively large bu t showed o nly
sligh t fluctuations and no peak (Fig. 2c).
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Fig. 1 Time course of nasal airway resistance (NAR) after
house dust (HD) antigen challenge in each type. 10) type I,
short-lasting type, n = 5; [b] type II, prolonged type, n = 8;
Ie) type III, biphasic type, n = 6.
Chang es in NAR
In the type I group, NAR increased signif icantly 3 h after
cha llenge co mpared with pre-chollenqe levels (P < 0 .05),
but percentage changes were a lways co ntained below
100% (Fig. 20) . The type II group showed one peak bet-
ween 1 h after challenge (75.24 ± 13. 86 em H20 / LIs)
and 3 h afte r cha llenge (72.40 ± 12 .79 em H20 / LIs),
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Changes in HIS extracted from the nasal
mucosal epithelial layer
In the type I group, the epithelial HIS levels increased
significantly from 0.23 ± 0.06 ng/mL before challenge
to 1.14 ± 0.91 ng/mL 7 h after challenge (P < 0.05)
and rapidly returned to the pre-challenge baseline there-
after (Fig. 2a). In the type II group, the pre-challenge
baseline was relatively high (1 .09 ± 0.49 ng/mL). An
increase to 1.45 ± 0.89 ng/mL was observed 10 min
after challenge, but no remarkable change was noted
thereafter. Histamine levels remained generally high in
this group (Fig. 2b). In the type III group, epithelial HIS
levels increased significantly from 0.37 ± 0.13 ng/mL
before challenge to 1.20 ± 0.49 ng/mL (P < 0.05) 1 h
after challenge and decreased thereafter to about 0.5
ng/mL. However, they increased again to 1.17 ± 0.63
ng/mL 7 h after challenge and remained at relatively
high levels (0.8 ng/mL) 9 h after challenge (Fig. 2c).
Changes in eosinophil cationic protein
extracted from the nasal mucosal epithelial
layer
In the type I group, ECP levels remained virtually un-
changed at about 2.5-5 Ilg/L until 5 h after challenge but
showed a tendency to increase thereafter, to 6.52 ± 1.98,
16.16 ± 9.76, and 11.86 ± 3.31 uq/L, at 5,7 and 9 h,
respectively, after challenge. Eosinophil cationic protein
levels at 7 h after challenge increased significantly from
pre-challenge baseline (P < 0.05). However, ECP levels
were relatively low in this group compared with the two
and increases at both time points were significant com-
pared with the pre-challenge baseline (21.79 ± 12.44 cm
H20/LIs; P < 0.05). Nasal airway resistance gradually
decreased thereafter and returned to the pre-challenge
baseline 9 h after challenge. Pre-challenge NAR was
approximately 10 times greater in this group than in the
two other groups (Fig. 2b). In the type III group, changes
in NAR showed a biphasic pattern with significant increa-
ses 1 h after challenge (53.30 ± 19.07 cm H20/L/s) and
5 h after challenge (53.01 ± 19.19 cm H20/LIs) com-
pared with the pre-challenge baseline (2.16 ± 0.25 cm
H20/LIs) (P < 0.01). Values obtained 3 h after challenge
were comparable with the pre-challenge baseline. Delayed
peaks were observed 7 h after challenge (36.51 ± 18.34
cm H20/LIs) and 9 h after challenge (37.44 ± 18.13 cm
H20/LIs; P < 0.05 compared with the pre-challenge
baseline, Fig. 2c).
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Fig. 2 Time course of nasal airway resistance (NAR, 0;
measured in cm H20/L/s), nasal secretion (OJ measured in
cm), eosinophil cationic protein (ECP) in nasal surface tissue
(0; measured in ~g/L), and histamine in nasal surface tissue
(6; measured in ng/mL) in (a) type 1 patients, (b) type 2
patients and (c) type 3 patients. Left Y axis represents NAR and
ECP. Right Y axis represents nasal secretion and histamine.
Bars represent SEM. *P < 0.05, **P < 0.0 1 compared with
the baseline (pre-challenge point).
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HIS versus nasal secretion amount
other groups (Fig. 2a). In the type II group, ECP levels
increased from 12.61 ± 7.26 ~g/L before challenge to
20.79 ± 13.26 ~g/L 1 h after challenge (1 st peak) and
decreased thereafter. However, they increased again to
39.49 ± 11.44 and 34.01 ± 14.1 0 ~g/L at 5 and 7 h,
respectively, after challenge. Eosinophil cationic protein
levels at 5 h after challenge increased significantly from
pre-challenge baseline (P < 0.05). increases in NAR and
ECP levels were not correlated. In the type ill group, the
pre-challenge baseline was higher than in the type II
group, and there was no immediate peak. Eosinophil
cationic protein levels began to increase 3 h after chal-
lenge and showed a peak 7 h after challenge and this level
was significantly more than the prechallenge baseline
(42.53 ± 22.73 ~g/L, Fig. 2c).
The coefficient of correlation (r) was 0.147, 0.165 and
0.071 in the type I, II and III groups, respectively, and
ECP and NAR were not correlated, regardless of group.
The coefficient of correlation was 0.222, 0.354 and
0.168 in the type I, II and III groups, respectively, and
NAR and nasal secretion amount were not correlated,
regardless of group.
The coefficient of correlation was 0.237, 0.135 and
0.101 in the type I, II and III groups, respectively, and His
levels and nasal secretion amounts were not correlated,
regardless of group.
Nasal secretion amount versus nasal
airway resistance
Inter-parameter correlation
Eosinophil cationic protein versus nasal
airway resistance
Eosinophil cationic protein versus histamine
The coefficient of correlation was 0.064, 0.674 and
0.505 in the type I, II and III groups, respectively.
Eosinophil cationic protein and histamine amounts were
significantly correlated in the type II and III groups. Nasal
airway resistance showed prolonged, biphasic changes,
(Fig. 3, P < 0.01).
Fig. 3 Correlation between eosinophil cationic protein (ECP)
and histamine in nasal surface tissue. (a) type I; short-lasting type,
n = 5, r = 0.064; (b) type II, prolonged type, n = 8, r = 0.679,
P < 0.01; and (c) type III, biphasic type, n = 6, r = 0.505,
P<O.01.
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Eosinophil
count
Before: few
IPR: very slight increase
LPR: moderate increase
Before: moderate
IPR: moderate increase
LPR: slight increase
Before: few
IPR: moderate increase
LPR: slight increase
------
--- ------_.._--
Before: moderate
LPR: moderate increase
Basophilic cell
count
Before: few
LPR: slight increase
Before: moderate
LPR: marked increase
Strong
Strong
Weak
-_._~~.~ -------~
High
Moderate
Types of nasal airway resistance after house dust challenge
NAR before Reaction to
provocation provocation
----- ----_._._--
Low
III. Biphasic type
II. Prolonged type
Table 1.
NAR type
I. Short-lasting type
NAR, nasal airway resistance; LPR, late phase response; IPR, immediate phase response.
DISCUSSION
Late-phase responseswere first reported (as airway obstruc-
tion which peaked 8-12 h after antigen inhalation) in
asthma patients in 1952.6 Thereafter, many investigators
have reported LPR in asthma patients, speculating that
eosinophil leukocyte appearing after challenge may have
been the cause of this phenomenon.' Late-phase responses
in nasal allergy patients are also presumed to be attribut-
able to migrating cells such as eosinophil leukocyte and BC,
which accumulate locally after challenge, as well as to
mediators released by these cells. Terada et 01. reported
eosinophil leukocyte as the most important factor,s-lO while
Naclerio and Lichtenstein emphasized BC as the major
factor, using nasal washing onclvsis.l:'? Infiltration of other
cells has also been reported as a causative Icctor.':' How-
ever, it remains unknown which cell types in nasal mucosa,
not in nasal secretion, playa main role in causing LPR.
In this study, the time courses of NAR were classified into
three types after HD antigen challenge: type I (short-
lasting type, five cases); type II (prolonged type, eight
cases); and type III (biphasic type, six cases). The inci-
dence of LPR was 30% if type III responses only were
regarded as LPR, and 70% if both type II and III responses
were regarded as LPR. In the literature, incidence ranged
from 50 to 75%.S-11,13-17 The incidence of pure LPR, in
which nasal mucosal swelling shows biphasic changes,
was slightly lower in the present study than in the previous
reports. Kojima and Asakura, who used mites in antigen
challenge, reported an incidence of 70%, which was the
same as the incidence obtained by US. 17 However, the
parameters for LPR used by Kojima and Asakura (who also
took increases in nasal secretion amount into account)
differed from ours.
Table 1 summarizes the characteristics in each of the
three types. Types I and II showed similar monophasic
reactions, however type II showed greater, more pro-
longed increases in NAR. Type II included three severe
rating cases (1 st test of case 1 and case 2, 1st and 2nd
tests of case 5). Severe rating cases in type I is 1st test of
case 9 only. Severe rating cases represented type I and
type II of change in NAR almost. Thus, the severity rating
of nasal symptoms is of concern with regard to changes
in NAR. Migrating cell infiltration, for example the
eosinophil leukocyte and BC in nasal mucosa, may con-
tribute to the severity of nasal symptoms.
In type II, NAR was elevated before antigen challenge,
and BC were predominant in the epithelial layer. It was
thought that this group's longer delay before a return to
the pre-challenge baseline was due to marked reactions
to antigen challenge and the severity rating of nasal symp-
toms. The discrepancy between delayed NAR, eosinophil
leukocyte and BC responses suggests that the baseline
NAR and the degree of responses determine time-course
changes in NAR after challenge, rather than that eosino-
phil leukocyte and BC infiltration determines delayed
nasal mucosal swelling. Types II and III showed similar
immediate-type reactions. However, while type II showed
protracted increases in NAR, a transient return to normal
was noted in type III. Nasal airway resistance may increase
earlier in type III than in type II due to different mecha-
nisms in the two types. Due to marked delayed increases
in eosinophil leukocyte and BC, these cells were suspec-
ted of being involved in the increases in NAR. The
following discussion explores this possibility.
In this study, sneezing occurred at a late stage after
challenge in both prolonged and biphasic types, but
whether it was due to non-specific hypersensitivity or IPR
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to accidental antigen exposure at this point in time was
unknown. Delayed increases in BC in the mucosal epithe-
lium did not always occur in patients who sneezed. This
fact suggests that sneezing was due to non-specific stimu-
lation in the presence of hypersensitivity, rather than to
the repetition of new immediate-type responses. The fact
that increases in nasal secretion or NAR did not correlate
with BC counts on the mucosal epithelium also suggests
that BC alone are not responsible for LPR, or that BC are
not the major mediator in LPR. Our findings are inconsis-
tent with the conclusion of Naclerio et 01., who found that
BC are the only major player in LPR in nasal allergy
patients. 11
We determined the levels of ECp, which is present in
the eosinophil matrix and has cytotoxic effects like
major base protein." as an index of the numbers of
eosinophil leukocyte in order to observe the behavior
of mucosal eosinophil leukocyte. Eosinophil cationic
protein levels showed delayed increases in all three
types, although increases were two- to three-fold grea-
ter in types II and III than in type I, indicating that
delayed marked nasal mucosal swelling results in an
increased infiltration of eosinophil leukocyte into the
mucosal epithelial layer, or that nasal mucosal swelling
increases as eosinophil leukocyte infiltration into the
mucosal epithelial layer increases. In type II, however,
increases in NAR were monophasic, and the role of
eosinophil leukocyte in this was unclear. In type III,
delayed increases in NAR were directly related to
eosinophil counts. In both individual data and total data,
however, there was no correlation of increases between
eosinophil leukocyte and NAR. Coupled with the fact
that eosinophil leukocyte counts in the nasal mucosal
epithelial layer increased even in type I, in which no
delayed nasal mucosal swelling was seen, this finding
suggests that delayed eosinophil leukocyte infiltration
occurs to some extent in all cases and that infiltrating
eosinophil leukocyte affect the nasal mucosa to differ-
ent extents depending on their number. However, no
definite conclusion could be drawn as to the extent to
which these eosinophil leukocyte contribute to the for-
mation of each type. Increases in NAR were not caused
only by eosinophil leukocyte infitration into nasal muc-
osa, but also by other mechanisms, such as mediator
reaction, neuropeptides (mainly by the carcitonine
gene related peptide (CGRP)) and/or bradykinin, neuro-
peptides and/or sympathetic nerve innervation, etc.
Rangi et 01. reported that nasal CGRP provocation
caused prolonged increases in nasal blood flow for 3 h
after chollenqe.!" These mechanisms of vessel dilata-
tion, however, could not be determined in this study.
Thus, we could not establish any more details of other
mechanisms.
In conclusion, delayed increases in NAR after antigen
challenge showed three different patterns. Furthermore,
the baseline NAR, severity rating of nasal symptoms, type
and number of cells migrating to the mucosal epithelial
layer, strength of immediate responses, and type of cells
observed in delayed cell infiltration seemed to act in con-
cert to determine the pattern of increase. Both eosinophil
leukocyte and BC cells seemed to infiltrate, although infil-
tration of either type alone seemed unlikely.
Our experiments had a number of methodological lim-
itations. In general, cells in scrapings are counted to
demonstrate increases in eosinophil leukocyte and BC.
However, accurate cell counting is difficult using this
method. It is also unclear whether cells released outside
the mucosa are involved in responses to challenge in vivo
settings and whether released cell counts accurately re-
flect intramucosal cell counts. For these reasons, we
destroyed cells obtained through scrape and expressed
the BC and eosinophil leukocyte as the amount of con-
tained His and ECp, respectively. Repeated scrapings may
also have affected NAR due to mechanical stimulation
(mucosal scraping). Nasal washing could also have
injured the nasal surface. We believe that the conven-
tional method is inappropriate for monitoring changes in
NAR over time, and that mucosal scraping is unavoidable
for this purpose.
Nasal airway resistance was determined by active
anterior rhinomanometry using a nozzle. In this method,
scale-out occurs due to unilateral marked nasal obstruc-
tion, so posterior rhinomanometry is more desirable. We
selected the anterior approach, however, because the
posterior approach requires great skill and is time-
consuming. Nasal secretion was determined using the
thread method." This method makes it possible to deter-
mine small amounts of secretion, although whether large
amounts of secretion could be determined was question-
able due to its limited ability to contain water.
Finally, HD mites are a perennial omnipresent antigen.
It is therefore possible that responses to challenge were
confounded with responses to unwanted, natural expo-
sure, although subjects were admitted to a sick room with
low mite levels during experiments.
Despite these limitations in methodology, our findings
were significant in that they showed that changes in NAR
can be classified into three types.
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